BioCentury
ARTICLE | Company News

Alaven Pharmaceutical LLC, Meda deal

September 6, 2010 7:00 AM UTC

Meda will acquire Alaven for $287 million in cash and assume $63 million of Alaven's net debt. Alaven markets prescription and OTC products for gastroenterology, women's health and anemia, including C...